| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |